Omeros Investigational Site

Milwaukee, Wisconsin 53226

We've found

1 trials

at this facility

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Status: Enrolling, Phase II
Updated: 1/11/2018

from

Milwaukee, WI

Use our guide to learn which trials are right for you!